CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-20 | Markel Stacy EVP Human Resources | Grant or award · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2019-03-20 | Lasaga Joseph Sr.VP Bus.Dev.Alliance Mgmt. | Grant or award · Employee Stock Option (right to buy) | +43,750 | 43,750 | ||
| 2019-03-20 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2019-03-20 | Mayer Eldon C. III EVP & Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-03-20 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-03-20 | Duliege Anne-Marie EVP & Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-03-20 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +237,500 | 237,500 | ||
| 2019-01-23 | Cabatuan Nelson Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2019-01-23 | Lasaga Joseph Sr.VP Bus.Dev.Alliance Mgmt. | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-01-23 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-01-23 | Markel Stacy EVP Human Resources | Grant or award · Employee Stock Option (right to buy) | +137,500 | 137,500 | ||
| 2019-01-23 | Mayer Eldon C. III EVP & Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-01-23 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +162,500 | 162,500 | ||
| 2019-01-23 | Duliege Anne-Marie EVP & Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +162,500 | 162,500 | ||
| 2019-01-23 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Employee Stock Option (right to buy) | +162,500 | 162,500 | ||
| 2019-01-23 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2018-10-12 | Cabatuan Nelson Principal Accounting Officer | Sale | −10,000 | $3.12 | $31K | 58 |
| 2018-09-17 | Duliege Anne-Marie EVP & Chief Medical Officer | Exercise or conversion | +115,500 | $2.54 | $293K | 115,500 |
| 2018-09-17 | Duliege Anne-Marie EVP & Chief Medical Officer | Sale | −115,500 | $3.50 | $404K | 0 |
| 2018-09-17 | Duliege Anne-Marie EVP & Chief Medical Officer | Exercise or conversion | +37,500 | $2.11 | $79K | 37,500 |
Page 15 of 16 · 310 trades